Abstract
Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians’ fingertips.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S36-S39 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 89 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 2023 |
Bibliographical note
Publisher Copyright:© 2023
Keywords
- androgenetic alopecia
- finasteride
- hair loss
- hair transplantation
- minoxidil
- platelet-rich plasma
PubMed: MeSH publication types
- Journal Article
- Review
- Research Support, Non-U.S. Gov't